Publicacións en colaboración con investigadores/as de University of Bologna (2)

2023

  1. Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170

    Blood, Vol. 142, Núm. 2, pp. 141-145

2022

  1. Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma

    Blood Advances